Centrient Pharmaceuticals boosting statins API manufacturing capacity

Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) — Summary: Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India. With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins. Centrient Pharmaceuticals’ statins are one […]

Continue Reading